COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Announces Second Quarter 2024 Financial Results: Revenue of $6.1 Million; 71% Gross Margin, and $83.0 Million in Liquidity to Support Growth
Zomedica Corp. reports 68% year-over-year growth in diagnostic revenues, driven by TRUFORMA and VETGuardian products. The company sees significant progress and strong financial results for the second quarter of 2024 -
-
-
COMMUNIQUÉ DE PRESSE
Zomedica Continues Global Expansion Through Strategic Partnership with SIRE Veterinario, S.A for Sales Expansion in Central America
Zomedica Corp. partners with SIRE Veterinario, S.A. to launch products in Costa Rica, expanding their international sales reach. Collaboration aims to provide cutting-edge veterinary solutions in the region -
-
-
COMMUNIQUÉ DE PRESSE
Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ET
Zomedica Corp. to host a conference call on August 14, 2024, at 4:30 p.m. ET to discuss Q2 2024 financial results. The company provides veterinary health products for animals
